- 专利标题： Chemosensory Receptor Ligand-Based Therapies
-
申请号： US13880719申请日： 2011-10-18
-
公开(公告)号： US20130281387A1公开(公告)日： 2013-10-24
- 发明人: Alain D. Baron , Martin R. Brown , Christopher R.G. Jones , Nigel R.A. Beeley
- 申请人： Alain D. Baron , Martin R. Brown , Christopher R.G. Jones , Nigel R.A. Beeley
- 申请人地址： US CA San Diego
- 专利权人： ELCELYX THERAPEUTICS, INC.
- 当前专利权人： ELCELYX THERAPEUTICS, INC.
- 当前专利权人地址： US CA San Diego
- 优先权： US61394716 20101019; US61394732 20101019; US61430914 20110107
- 国际申请： PCT/US11/56771 WO 20111018
- 主分类号： A61K31/706
- IPC分类号： A61K31/706 ; A61K45/06 ; A61K31/194 ; A61K31/165 ; A61K31/255 ; A61K31/661 ; A61K31/662 ; A61K31/44 ; A61K31/5377 ; A61K31/4439 ; A61K31/4545 ; A61K31/426 ; A61K31/42 ; A61K31/341 ; A61K31/704 ; A61K31/20 ; A61K31/7008
摘要：
Provided herein are methods for treating conditions associated with a chemosensory receptor, including diabetes, obesity, and other metabolic diseases, disorders or conditions by administering a composition comprising a chemosensory receptor ligand. Also provided herein are chemosensory receptor ligand compositions and methods for the preparation thereof for use in the methods of the present invention.